
TSE:BNS
This summary was created by AI, based on 30 opinions in the last 12 months.
The Bank of Nova Scotia (BNS) has elicited mixed reviews from experts. Some highlight its strong positioning for future growth due to investments in GenAI and a favorable regulatory environment that allows for increased lending capacity. However, others express concerns about BNS's performance relative to its Canadian peers, noting it as the weakest among them despite a decent dividend yield of around 4.5% and recent strategic moves to invest in the U.S. market through KEY. While some analysts see potential for long-term gains, particularly with the new CEO at the helm, others urge caution citing stagnant loan growth and rising provisions for credit losses (PCLs). The overall sentiment reflects a blend of optimism for its turnaround and skepticism about its ability to catch up to its competitors amidst ongoing economic challenges.
(A top pick October 18/17, down 1%) This one is still in the starting gate. This is the heaviest weighted bank in their portfolio. Scotiabank is the poster child for emerging market exposure with operations in Mexico, Latin America, and South America. They are getting bigger in those geographies. And have double downed on wealth management with the acquisition of MD Management. Sentiment changing in emerging markets should put it back on track.
This is part of his Canadian portfolio. From the point of view of Canadian holdings, this is a good company to own because they’ve made two good acquisitions on the wealth management side. These will be accretive. Also the market seems to be successfully absorbing higher interest rates. Over the longer term, this has been a solid performer and it offers a good dividend yield. That makes it an interesting story even from the global perspective. (Analysts’ price target is $86.29)
They've been punished more than their peers. They just acquired some top money managers and the street punished them. There'll be a write-off this quarter, but long-term these additions will benefit BNS. Pays a great dividend and should be enough growth to perform well. Well-managed. (Analysts' price target: $86.40)
(Past Top Pick, June 7, 2017, Up 4%) They're exposed to South America which are tied to commodities. So if there are commodity worries, then it effects this stock. He believes in management's investments in technology and that their Latin American presence will pay off in the long run. It remains a major holding for him and he will stick with it. It's a good buy here.
The stock is close to its 52-week low, dragged down by 2 factors: (a) It is the most international bank and EM markets have struggled this year. A strong US dollar hurts emerging markets. (b) They have done acquisitions and issued shares in the process. He owns this stock despite its price pressure. “You don’t ever go really wrong by buying the Canadian banks.” They are an oligopoly, they have great management teams and they always tend to recover. This is a trading opportunity: good value, good volatility, but weak price momentum at this time.
This is the only Canadian bank he owns. He likes it because (a) it has the least exposure to Canada of the Canadian banks and (b) it is the most international bank, having operations in Latin America and Asia. ScotiaBank has been making acquisitions that use its current capital and will take time to increase its earnings. The market is punishing it over the short term, but these are great long-term acquisitions.